June 1, 2016 News by Patricia Silva, PhD #CMSC16 – MS Expert Fred Lublin Discusses Relevance of MS Relapses Dr. Fred Lublin,Ā a renowned multiple sclerosis (MS) expert atĀ Mount Sinai Medical Center, helped launch theĀ Consortium of Multiple Sclerosis Centers (CMSC) 2016 Annual Meeting,Ā June 1 – 4, in National Harbor, Md. with the John F. Kurtzke Memorial Lecture he titledĀ āDo Relapses Really Matter?ā āHow relapses influence disease worsening,…
December 26, 2014 News by admin Long-Term Multiple Sclerosis Progress Can Be Better Determined Using NEDA Standard A study published on December 22 in JAMA Neurology emphasizes that a standard measurement used to gauge multiple sclerosis (MS) symptoms, known as “no-evidence-of-disease-activity” (NEDA) is important for determining how the disease will progress long-term. MS is the most common degenerative neurological condition that affects young adults worldwide.